Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Phase I/Ib Study of Paclitaxel in Combination With VS-6063 in Patients With Advanced Ovarian Cancer [Phase 1]
This is a completed Phase I/Ib trial evaluating paclitaxel in combination with VS-6063 (defactinib) in patients with advanced ovarian cancer…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: A Study of Bevacizumab in Ovarian Cancer or Primary Peritoneal Cancer Where Doxil or Topotecan Therapy Has Failed [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating bevacizumab in patients with ovarian cancer or primary perit…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Caelyx in Combination With Carboplatin in Patients With Ovarian Cancer Recurrent Within Six to Twelve Months After Initial Carboplatin and Paclitaxel Chemotherapy (P03625) [Phase 2]
A Phase 2 study evaluating the safety and efficacy of Caelyx in combination with carboplatin in patients with ovarian cancer that recurs wit…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites [Phase 2]
Phase 2 study of AZD9150 (danvatirsen), a STAT3 antisense oligonucleotide, in patients with malignant ascites associated with ovarian or gas…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: A Trial to Evaluate Efficacy and Safety of the Combination Therapy of Genexol®-PM Plus Carboplatin® Compared to Genexol® Plus Carboplatin® as a Firstline Treatment in Subjects With Ovarian Cancer [Phase 2]
A Phase 2 randomized trial evaluating efficacy and safety of Genexol-PM plus carboplatin versus Genexol plus carboplatin as first-line treat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Blood Samples From Patients on a Clinical Trial to CINV During HSCT
This is an update on a clinical trial involving collection of blood samples from patients undergoing chemotherapy-induced nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 3]
A Phase 3 trial of moxifloxacin to prevent bacterial infections in patients who have undergone a donor stem cell transplant was terminated.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: ROGYcare: The Impact of a Cancer Survivorship Care Plan on Patient Reported Outcomes and Health Care Providers [NA]
A completed clinical trial (ROGYcare) evaluating the impact of a cancer survivorship care plan on patient-reported outcomes and health care …
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial results for GM-CSF (sargramostim) in women with recurrent ovarian cancer (including fallopian tube cancer) have been …
-
CLINICAL_TRIALS research · 2017-05-05Clinical Trial Update: Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
This clinical trial update describes a study collecting tumor tissue samples from patients who have undergone surgery for advanced ovarian c…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Temsirolimus, Carboplatin, and Paclitaxel as first-line therapy for newly diagnosed stage III-IV clear cell ovarian…
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: Preoperative Ascites Drainage Versus Standard Care for Patients With Advanced Ovarian Cancer [NA]
A clinical trial evaluating preoperative ascites drainage versus standard care in patients with advanced ovarian cancer has been suspended.
-
CLINICAL_TRIALS withdrawal · 2017-05-02Clinical Trial Update: DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of DCVax-L vaccination combined with CD3/CD28-costimulated autologous T-cells for recurrent ovarian cancer or primary peri…
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Identification and Characterization of Ovarian Cancer and Endometrial Cancer Specific Biomarkers in Vaginal Fluids [NA]
The clinical trial aimed to identify biomarkers for ovarian and endometrial cancers in vaginal fluids, but the study has been withdrawn.
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: Cohort Study of Risk Reducing Salpingectomy [NA]
This document provides an update on a completed cohort study evaluating risk-reducing salpingectomy as a strategy to lower ovarian cancer ri…
-
CLINICAL_TRIALS withdrawal · 2017-04-24Clinical Trial Update: Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
A Phase 1 clinical trial of talazoparib in patients with advanced or metastatic solid tumors unsuitable for surgery and with liver or kidney…
-
CLINICAL_TRIALS trial_result · 2017-04-21Clinical Trial Update: Phase 1 Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer [Phase 1]
A Phase 1 trial of an ImmunoVaccine Technologies cancer vaccine for advanced ovarian cancer, fallopian tube cancer, or peritoneal cancer has…
-
CLINICAL_TRIALS withdrawal · 2017-04-21Clinical Trial Update: N-acetylcysteine Given IV With Cisplatin and Paclitaxel in Patients With Ovarian Cancer [Phase 1]
A Phase 1 trial of intravenous N-acetylcysteine with cisplatin and paclitaxel for ovarian cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary [Phase 1]
A Phase 1 clinical trial evaluating contrast-enhanced ultrasonography to diagnose early-stage ovarian cancer in women with an adnexal mass u…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Ensuring Communication in Hospice by Oncology Study (ECHO) [NA]
The ECHO hospice communication trial, sponsored by Massachusetts General Hospital, has completed and involved patients with ovarian, cervica…
-
CLINICAL_TRIALS other · 2017-04-17Clinical Trial Update: Expanded Access Protocol for Niraparib in Patients With Recurrent Ovarian Cancer
Expanded access protocol update for Niraparib in patients with recurrent ovarian cancer, sponsored by Tesaro, Inc. The document notes the pr…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion [Phase 2]
Phase 2 clinical trial update examining intraperitoneal chemotherapy with or without bevacizumab for ovarian cancer with peritoneal adhesion…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Paclitaxel, Carboplatin and Vorinostat for the Treatment of Advanced Stage Ovarian Carcinoma [Phase 1, Phase 2]
A phase 1/2 trial of paclitaxel, carboplatin, and vorinostat for advanced ovarian cancer was terminated; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Trial of Pimasertib With SAR245409 or Placebo in Ovarian Cancer [Phase 2]
Phase 2 trial investigating pimasertib with SAR245409 or placebo in ovarian cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors [NA]
The clinical trial update notes completion of a cognitive-behavioral intervention designed to help cancer survivors manage worry, uncertaint…